2023 PDA Robotics and Automation Conference

May 3-4, 2023 | Netherlands

2023 PDA Robotics
We are looking forward to welcoming you to the 2023 PDA Robotics and Automation Conference taking place on 03 - 04 May 2023 in Amsterdam, The Netherlands!
Register Now

Spotlight

Once the industry has normalized after a turbulent 2020,
life sciences leaders can still count on continued change.
The future will be challenging at best without the support
of next-gen BI as life sciences navigate their businesses
through new or growing competition, economic recovery,
regulatory and political pressures, barriers to market access,
and an increased demand for personalized medicine.


OTHER UPCOMING CONFERENCES

CPhI North America

April 25-27, 2023 | USA

As the only pharma event in the Americas region to cover the end-to-end supply chain, it’s the ONLY place you’ll be able to meet suppliers from every area of the pharma industry.
Register Now

Drug Formulation & Drug Delivery

April 24-25, 2023 | USA

Pharmacokinetics vs. Pharmacodynamics. The main difference between pharmacokinetics and pharmacodynamics is that pharmacokinetics is defined as the movement of medicines through the body, whereas pharmacodynamics (PD) is defined as the body's natural response to medicines.
Register Now

3rd Global Summit on Pharmaceutical Research

May 4-5, 2023 | UK

We are very honour to welcome you all to attend the “Global Pharma Summit-2023” which is happening on May 04-05, 2023 in London, UK.
Register Now

International Conference on Pharmaceutical Formulations

April 7, 2023 | Netherlands

ISER is delighted to welcome you to the International Conference on Pharmaceutical Formulations (ICPF-23) at Amsterdam, Netherlands on 7th April`2023.
Register Now

Spotlight

Once the industry has normalized after a turbulent 2020,
life sciences leaders can still count on continued change.
The future will be challenging at best without the support
of next-gen BI as life sciences navigate their businesses
through new or growing competition, economic recovery,
regulatory and political pressures, barriers to market access,
and an increased demand for personalized medicine.

resources